🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2021-01-01
Trial ID
NCT06333561
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Status
Unknown
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2021-01-01
Trial ID
NCT05582278
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
Primary liver cancer is one of the most common malignant tumors in the worl...
Status
Recruiting
Location
Huapeng Sun
Start Date
2024-06-01
Trial ID
NCT06420440
Treatments Being Tested
Surgery is the main curative treatment for hepatocellular carcinoma(HCC) pa...
Status
Unknown
Location
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-06-01
Trial ID
NCT06463444
Treatments Being Tested
Patients with unresectable hepatocellular carcinoma will receive hepatic ar...
Status
Completed
Location
Guangxi Medical University Cancer Hospital
Start Date
2022-11-10
Trial ID
NCT05532319
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Completed
Location
The first hospital of China medical university
Start Date
2021-01-01
Trial ID
NCT06631326
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Recruiting
Location
The first hospital of China medical university
Start Date
2024-09-16
Trial ID
NCT06632093
Treatments Being Tested